Advocacy & Legislative Updates

Articles
Data pager
Data pager
12
Page size:
PageSizeComboBox
select
 18 items in 2 pages
Show all 18
FDA's New Stability Testing Mandate Sparks Concern Over Potential PET Drug Shortages
Last fall, the FDA stressed that the PET Good Manufacturing Practices require stability testing at each facility annually. SNMMI opposes that change, which could have a strong negative impact on the supply of PET drugs in the U.S.
Subject: Advocacy & Legislative Updates, SNMMI News
Aug 21, 2024
8/21/2024 12:00:00 AM
Neuroendocrine Tumors Included in FY25 Defense Appropriations Report
The Senate Appropriations Committee included neuroendocrine tumors (NETs) on this list of conditions eligible for dedicated research funding.
Subject: Advocacy & Legislative Updates
Aug 08, 2024
8/8/2024 12:34:00 PM
SNMMI Opposes Conversion Factor Cuts to the Medicare Physician Fee Schedule in CMS’ Proposed FY25 Ru
On Tuesday, July 9, the Centers for Medicare & Medicaid Services (CMS) released the proposed rule for the 2025 Medicare Physician Fee Schedule (MPFS). Below are key takeaways SNMMI would like to make our members aware of.
Subject: Advocacy & Legislative Updates, Coding & Reimbursement
Jul 17, 2024
7/17/2024 4:52:56 PM
Reflections on My Henkin Fellowship
These two words are the theme of the 2024 SNMMI Annual Meeting. They also were the theme to my experience as the 2024 SNMMI Henkin Fellow. Self-admittedly, I applied for the Henkin Fellowship because I knew nothing about nuclear medicine policy and g
Subject: Advocacy & Legislative Updates
May 21, 2024
5/21/2024 12:00:00 AM
Nuclear Medicine Funding Language in CDRMP
President Joe Biden signed H.R. 2882, the second FY 2024 appropriations package titled Further Consolidated Appropriations Act, 2024 into law. The signing of this bill completed the FY 2024 appropriations process.
Subject: Advocacy & Legislative Updates
Apr 15, 2024
4/15/2024 12:00:00 AM
HPRA March 2024 Newsletter
SNMMI will be hosting our annual Hill Day on Friday, April 5, in Washington, DC. Approximately 65 SNMMI members, patients, and industry colleagues will be coming to Washington to meet with House and Senate congressional staff. Attendees will be discu
Subject: Advocacy & Legislative Updates
Mar 13, 2024
3/13/2024 12:00:00 AM
Biden Administration Finalizes Rule on Prior Authorization
The Biden administration finalized a rule that will simplify Medicare Advantage, Medicaid, and other government-sponsored health plans’ use of prior authorization. The rule, finalized on January 17, 2024, requires government-sponsored health plans to
Subject: Advocacy & Legislative Updates
Feb 27, 2024
2/27/2024 12:00:00 AM
CMS Removes NCD 220.6.20 From Publication 100-03
Effective October 13, 2023, CMS removed NCD 220.6.20 from Publication 100-03, the NCD Manual, ending coverage with evidence development (CED) for positron emission tomography (PET) beta amyloid imaging and permitting Medicare coverage determinations
Subject: Advocacy & Legislative Updates
Jan 03, 2024
1/3/2024 12:00:00 AM
HPRA December 2023 Newsletter
On November 2, 2023, CMS released the OPPS CY 2024 final rule. The proposed rule included a request for comment on unbundling radiopharmaceuticals, but the final rule did not make any changes to the bundling policy. All diagnostic radiopharmaceutical
Subject: Advocacy & Legislative Updates
Dec 14, 2023
12/14/2023 12:00:00 AM
CMS Releases Final Rule on the Hospital Outpatient Prospective Payment System
In early November, CMS released the Hospital Outpatient Prospective Payment System (OPPS) CY 2024 final rule. The proposed rule included a request for comment on unbundling/unpackaging radiopharmaceuticals, but the final rule did not make any changes
Subject: Advocacy & Legislative Updates
Dec 07, 2023
12/7/2023 12:00:00 AM